We are live on ! Find out more
VLC

Van Leeuwen & Company Portfolio holdings

AUM $197M
1-Year Est. Return 44.16%
This Fund
S&P 500
This Quarter Est. Return
-11.34%
1 Year Est. Return
+44.16%
3 Year Est. Return
+75.42%
5 Year Est. Return
+199.79%
10 Year Est. Return
AUM
$119M
AUM Growth
-$16.6M
Cap. Flow
+$1.52M
Cap. Flow %
1.28%
Top 10 Hldgs %
55.13%
Holding
71
New
9
Increased
25
Reduced
14
Closed
18

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$6.18M
2
T icon
AT&T
T
+$5.55M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.74M
4
FXI icon
iShares China Large-Cap ETF
FXI
+$3.37M
5
PFE icon
Pfizer
PFE
+$2.54M

Top Sells

Rank Stock Value
1
CNP icon
CenterPoint Energy
CNP
+$2.53M
2
AMP icon
Ameriprise Financial
AMP
+$1.76M
3
TSM icon
TSMC
TSM
+$1.72M
4
AAP icon
Advance Auto Parts
AAP
+$1.61M
5
WAB icon
Wabtec
WAB
+$1.53M

Sector Composition

Rank Sector Weight
1 Healthcare 17.1%
2 Communication Services 13.79%
3 Technology 13.15%
4 Financials 10.12%
5 Consumer Discretionary 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPLA icon
26
LPL Financial
LPLA
$28.4B
$1.27M 1.07%
6,897
+275
+4% +$52.2K
TFC icon
27
Truist Financial
TFC
$64.7B
$1.26M 1.06%
26,636
+57
+0.2% +$2.81K
QQQ icon
28
Invesco QQQ Trust
QQQ
$481B
$1.25M 1.05%
4,457
+42
+1% +$13K
CTVA icon
29
Corteva
CTVA
$51.3B
$1.09M 0.92%
20,230
+193
+1% +$11.2K
MRK icon
30
Merck
MRK
$317B
$1.02M 0.85%
11,188
-5,255
-32% -$466K
CSX icon
31
CSX Corp
CSX
$94.2B
$984K 0.82%
33,864
-78
-0.2% -$2.54K
SPY icon
32
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$956K 0.8%
2,534
+56
+2% +$22.9K
XLF icon
33
State Street Financial Select Sector SPDR ETF
XLF
$58.6B
$857K 0.72%
27,248
-165
-0.6% -$5.7K
COST icon
34
Costco
COST
$419B
$846K 0.71%
1,765
-450
-20% -$228K
ON icon
35
ON Semiconductor
ON
$19B
$758K 0.64%
+15,057
New +$839K
LIN icon
36
Linde
LIN
$227B
$728K 0.61%
+2,533
New +$791K
GE icon
37
GE Aerospace
GE
$400B
$722K 0.6%
18,200
+88
+0.5% +$4.26K
UL icon
38
Unilever
UL
$137B
$712K 0.6%
+13,802
New +$703K
BA icon
39
Boeing
BA
$189B
$563K 0.47%
4,121
+511
+14% +$75.4K
C icon
40
Citigroup
C
$229B
$551K 0.46%
11,990
+100
+0.8% +$5K
CVX icon
41
Chevron
CVX
$368B
$500K 0.42%
3,454
-20
-0.6% -$3.31K
NSC icon
42
Norfolk Southern
NSC
$76.7B
$461K 0.39%
2,028
-22
-1% -$5.4K
XOM icon
43
ExxonMobil
XOM
$632B
$422K 0.35%
4,928
+249
+5% +$22.5K
PG icon
44
Procter & Gamble
PG
$342B
$330K 0.28%
2,295
+50
+2% +$7.51K
INTC icon
45
Intel
INTC
$509B
$321K 0.27%
8,578
PVH icon
46
PVH
PVH
$4.12B
$305K 0.26%
5,366
DIS icon
47
Walt Disney
DIS
$179B
$299K 0.25%
3,165
+66
+2% +$7.33K
PEG icon
48
Public Service Enterprise Group
PEG
$37.6B
$282K 0.24%
4,459
BP icon
49
BP
BP
$107B
$280K 0.23%
9,871
+268
+3% +$8.21K
AVGOP
50
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
$244K 0.2%
162

Similar funds

Van Leeuwen & Company's Q2 2022 Portfolio in Review

As of Q2 2022, Van Leeuwen & Company held 71 positions worth $119M, down 12% from $136M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Van Leeuwen & Company's Q2 2022 filing shows 9 new, 25 increased, 14 reduced and 18 closed positions. Its largest new stake was AT&T: 278,510 shares worth $5.84M. The largest sale was CenterPoint Energy, an estimated $2.53M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 7.5% a quarter earlier, followed by Communication Services and Technology.

  • Van Leeuwen & Company's largest Q2 2022 buy was AT&T: 278,510 shares worth $5.84M.
  • Van Leeuwen & Company added most to Bristol-Myers Squibb in Q2 2022, an estimated $6.18M increase.
  • Van Leeuwen & Company's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $873K.
  • Van Leeuwen & Company fully exited CenterPoint Energy in Q2 2022, selling an estimated $2.53M.
  • Van Leeuwen & Company's ten largest holdings make up 55% of its $119M portfolio in Q2 2022.
  • Van Leeuwen & Company opened 9 new positions and closed 18 in Q2 2022.
  • Van Leeuwen & Company's portfolio value fell 12% quarter-over-quarter to $119M.

Based on Van Leeuwen & Company's 13F filing for Q2 2022, filed 11 Aug 2022.